Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
In this episode of the Life Science Success Podcast my guest is Vadim Klyushnichenko, Ph.D, Vadim is the VP Pharmaceutical Development at Scripps Research. He has over 25 years of progressive experience in Global Bio/Pharmaceutical...
In this episode of the Life Science Success Podcast my guest is Vadim Klyushnichenko, Ph.D, Vadim is the VP Pharmaceutical Development at Scripps Research. He has over 25 years of progressive experience in Global Bio/Pharmaceutical Development from Discovery to Clinical and Commercial Manufacturing.
Introduction
02:35 Tell listeners a little bit about himself.
06:42 Tell us more specifically about your current role and responsibilities at Scripps. What is it that, you do on a daily basis?
10:58 What does the process look like as you're going from, essentially the lab that you're in at Scripps to a CDMO, what does that process look like?
15:05 What's your work? Previously at places like Catalent and Pfizer and all these other, larger scale companies, how is working for Scripps or caliber the same?
21:27 So in your role today, what are some of the biggest challenges that you face?
25:04 Where do you see the biggest opportunities in your current role then?
25:57 There are some questions that I like to ask every guest.
-What Inspires you?
26:44 -What concerns you?
28:20 -What excites you?
Please check out our Life Science Success Resources. You will find tools that will support growing companies and books for authors I have interviewed.
Dr.Klyushnichenko, VP Pharmaceutical Development and Quality at Calibr, the division of the Scripps Research Institut, La Jolla, CA Dr.Klyushnichenko has over 20 years of experience in Bio/Pharmaceutical Development and Manufacturing. His Drug Development experience includes the production of small molecules and proteins as well as their formulation in micro- and nano-particles, controlled-release systems for oral, injectable, implantable and pulmonary delivery. Currently, Vadim is responsible for the development of small molecules, biologics, gene and cell therapy products as well as their supply chain, which involves multiple CDMOs in the US, EU, India and China. Vadim has developed his growing managerial and scientific responsibilities working as VP of Drug Development at Paragon BioServices, Terapio Corporation, and Coldstream Laboratories Inc., Lab Head/Principal Scientist at Wyeth/Pfizer, Sr.Scientist at Baxter, Altus and Aventis. Vadim has received his B.S. in Physics from Moscow Institute of Physics and Technology (FizTech), Ph.D. in Chemistry from the Russian Academy of Sciences, and continued his postdoctoral research in Germany and Canada. He has received a Certificate in Management and Business Administration from Harvard University.
In this episode of Life Science Success, host Don Davis has a conversation with Dr. Mohit Jain, a physician scientist with extensive experience in physiology, biomedicine, and mass spectrometry. Dr. Jain shares his unique journey from clinical...
This week on Life Science Success, we are thrilled to welcome back Elizabeth Smalley as our guest. Elizabeth is the VP, Product Management, Data & Analytics at ArisGlobal, where she plays a pivotal role in steering the company’s strategic...
In this episode of Life Science Success, my guest is Cristian Massacesi MD. Cristian is the Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca. In the interview, we will discuss his start in oncology, his career...
This week on the Life Science Success podcast, my guest is Thomas Farb-Horch. Thomas is the CEO of Thrive Bio. He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have …
